Skip to main content

Table 2 Capillaroscopic abnormalities in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

From: Peripheral microangiopathy in precapillary pulmonary hypertension: a nailfold video capillaroscopy prospective study

 

IPAH

CTEPH

Healthy controls

P-value*

N

14

14

30

 

Avascular areas (n/mm)

0.75 ± 0.26+

0.67 ± 0.42#

0.15 ± 0.2+#

 < 0.001

Avascular areas, n (%)

13 (92.8)

12 (85.7)

8 (26.6)

 < 0.001

Capillary width (μm)

35.1 ± 5.1+

39.2 ± 4.6#

29.5 ± 4.3+#

 < 0.001

Arterial limb (μm)

10.2 ± 2.2+

10.3 ± 1.5#

7.4 ± 1.3+#

 < 0.001

Venous limb (μm)

12.4 ± 2.4+

12.6 ± 2.4#

8.8 ± 1.4+#

 < 0.001

Irregularly enlarged (loops/mm)

1.4 ± 1.2+

1.2 ± 0.7#

0.4 ± 0.5+#

 < 0.001

Capillary length (μm)

323.8 ± 84.9

315.2 ± 107.7

313.2 ± 83.9

0.99

Edema, n (%)

3 (21.4)

0

0

Microhemorrhages (n/mm)

0.25 (0.25)

0.12 (0.4)

0 (0)

 < 0.001

Microhemorrhages, n (%)

8 (57.1)

5 (35.7)

0

 < 0.001

Thrombosis (n/mm)

2.2 ± 0.8$

3.2 ± 1.3$#

1.4 ± 0.8#

 < 0.001

Disorganized capillaries (loops/mm)

0.5 ± 0.4

0.4 ± 0.3

0.2 ± 0.4

0.079

Shape abnormalities (loops/mm)

1.8 ± 1.0$

3.1 ± 1.2$#

1.1 ± 0.8#

 < 0.001

Ramified capillaries (loops/mm)

0.5 ± 0.4+

0.7 ± 0.3#

0.2 ± 0.2+#

 < 0.001

  1. Categorical variables are presented as frequency and percentage, n (%)
  2. Continuous variables are presented as mean value ± standard deviation or median value and interquartile range
  3. IPAH idiopathic pulmonary arterial hypertension, CTEPH chronic thromboembolic pulmonary hypertension
  4. *A p-value < 0.05 is considered statistically significant. Comparisons were made among the three groups
  5. +Statistical significance between IPAH and controls. P-value < 0.01
  6. #Statistical significance between CTEPH and controls. P-value < 0.01
  7. $Statistical significance between CTEPH and IPAH. P-value < 0.01